{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:02:50Z","timestamp":1789754570129,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.radonc.2026.111525","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:40:38Z","timestamp":1775230838000},"page":"111525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Intra-fraction errors and inter-fraction deformation during pancreas SBRT: Analysis and predictability of dose variations for upper gastrointestinal organs"],"prefix":"10.1016","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0360-3275","authenticated-orcid":false,"given":"Mauro","family":"Loi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Doro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Zani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Aquilano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Valzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Simontacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Livi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111525_b0005","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2026.111525_b0010","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2026.111525_b0015","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111525_b0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2020.11.006","article-title":"A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): long-term outcome","volume":"155","author":"Teriaca","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13014-021-01782-w","article-title":"Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: does inter-and intra-fraction treatment variation warrant adaptive therapy?","volume":"16","author":"Hill","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2019.01.020","article-title":"Pancreatic cancer treated with SBRT: effect of anatomical interfraction variations on dose to organs at risk","volume":"134","author":"Loi","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0035","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ijrobp.2020.10.021","article-title":"Adaptive Radiation Therapy (ART) strategies and Technical Considerations: a State of the ART Review from NRG Oncology","volume":"109","author":"Glide-Hurst","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111525_b0040","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/j.prro.2018.08.010","article-title":"Dosimetric Benefits and Practical pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer","volume":"9","author":"El-Bared","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0045","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ijrobp.2025.03.039","article-title":"Development of Multiparametric Prognostic Models for Stereotactic magnetic Resonance Guided Radiation Therapy of Pancreatic Cancers","volume":"122","author":"Michalet","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111525_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110064","article-title":"Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: a multi-center, open-label phase 2 study","volume":"191","author":"Chuong","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0055","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ijrobp.2023.05.023","article-title":"A Multi-institutional phase 2 Trial of Ablative 5-Fraction Stereotactic magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and locally Advanced Pancreatic Cancer","volume":"117","author":"Parikh","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111525_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.842402","article-title":"Stereotactic MR-guided radiotherapy for pancreatic tumors: dosimetric benefit of adaptation and first clinical results in a prospective registry study","volume":"12","author":"Michalet","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0065","article-title":"Online adaptive radiation therapy and opportunity cost","volume":"8","author":"McComas","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.radonc.2018.11.019","article-title":"Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy","volume":"132","author":"Bohoudi","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.radonc.2019.09.016","article-title":"A model-based patient selection tool to identify who may be at risk of exceeding dose tolerances during pancreatic SBRT","volume":"141","author":"Magallon-Baro","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.prro.2013.06.004","article-title":"Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus","volume":"4","author":"Jabbour","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.radonc.2020.07.052","article-title":"ESTRO ACROP guidelines for target volume definition in pancreatic cancer","volume":"154","author":"Brunner","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1120\/jacmp.v14i5.4333","article-title":"Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with cyberknife","volume":"14","author":"Descovich","year":"2013","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2026.111525_b0095","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/030089161109700415","article-title":"Geometry of volumes in radiotherapy planning. a new method for a quantitative assessment","volume":"97","author":"Tomatis","year":"2011","journal-title":"Tumori"},{"key":"10.1016\/j.radonc.2026.111525_b0100","doi-asserted-by":"crossref","first-page":"S3625","DOI":"10.1016\/S0167-8140(24)02346-6","article-title":"2066: a simple parameter to guide plan optimization for robotic pancreas SBRT","volume":"194","author":"Zani","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","article-title":"UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy","volume":"30","author":"Hanna","year":"2018","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0110","article-title":"Preoperative single fraction breast radiotherapy: Intra-fraction geometric uncertainties and dosimetric implications. Phys","volume":"112","author":"Masi","year":"2023","journal-title":"Medica"},{"key":"10.1016\/j.radonc.2026.111525_b0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-540-69886-9_3","article-title":"Patient alignment and target tracking in radiosurgery of soft-tissue tumors using combined fiducial and skeletal structures tracking techniques","author":"Wu","year":"2007","journal-title":"Treat Tumors that Move with Respir"},{"key":"10.1016\/j.radonc.2026.111525_b0120","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1118\/1.3596527","article-title":"Correlation and prediction uncertainties in the CyberKnife Synchrony respiratory tracking system","volume":"38","author":"Pepin","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2026.111525_b0125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijrobp.2008.12.041","article-title":"Clinical accuracy of the respiratory tumor tracking system of the cyberknife: assessment by analysis of log files","volume":"74","author":"Hoogeman","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111525_b0130","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijrobp.2013.02.022","article-title":"Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated","volume":"86","author":"Chuong","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111525_b0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.phro.2022.07.005","article-title":"Technical feasibility of online adaptive stereotactic treatments in the abdomen on a robotic radiosurgery system","volume":"23","author":"Milder","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111525_b0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijrobp.2021.03.050","article-title":"Comparison of daily online plan adaptation strategies for a cohort of pancreatic cancer patients treated with SBRT: plan adaptation strategies for pancreatic SBRT","volume":"111","author":"Magallon-Baro","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111525_b0145","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s13246-023-01324-6","article-title":"Assessment of interfraction dose variation in pancreas SBRT using daily simulation MR images","volume":"46","author":"Young","year":"2023","journal-title":"Phys Eng Sci Med"},{"key":"10.1016\/j.radonc.2026.111525_b0150","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1976\/aaf9ae","article-title":"4DMRI-based analysis of inter - and intrafractional pancreas motion and deformation with different immobilization devices","volume":"5","author":"Dolde","year":"2019","journal-title":"Biomed Phys Eng Express"},{"key":"10.1016\/j.radonc.2026.111525_b0155","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2025.7013","article-title":"Lessons learned about acute and late toxicity after two decades of experience with pancreatic SBRT","volume":"23","author":"Ellsworth","year":"2025","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026003646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026003646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:06:29Z","timestamp":1789751189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026003646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":31,"alternative-id":["S0167814026003646"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111525","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intra-fraction errors and inter-fraction deformation during pancreas SBRT: Analysis and predictability of dose variations for upper gastrointestinal organs","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111525"}}